Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offer...(arma is a worldwide leading specialty ph...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
Date:3/26/2008
arma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at http://www.bayerscheringpharma.de.
Forward-Looking Statements
This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead
to material differences between the actual future results, financial
situation, development or performance of the company and the estimates
given here. These factors include those discussed in Bayer's public reports
which are available on the Bayer website at http://www.bayer.com. The
company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
Contact Details
Bayer HealthCare
Oliver Renner, Tel: +49-30-468-12431
Head Global Public Relations & Public Affairs
oliver.renner@bayerhealthcare.com
MEDRAD
Luanne Radermacher, Tel: +1-724-940-7968
Director, Corporate Affairs
'/>"/>
| SOURCE Bayer HealthCare Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
2. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
3. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
4. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
7. LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems
8. Caliper Life Sciences to Present at Lehman Brothers Global Healthcare Conference
9. Misys and Allscripts Create a Leader in Healthcare Software
10. Angiotech to participate in Lehman Brothers Healthcare Conference
11. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
(Date:11/23/2009)...SAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioScience...evelopmentcompanythatidentifiesandadvancesadiverse...sstagesofdevelopment,todayreportedthatCytopia(ASX:...ingCYT387,apotent,orally-administeredJAK1/JAK2inhi...ter,Minnesota.AproposaltomergeCytopiaintoYMhasbeen...
(Date:11/23/2009)...INVIEW,Calif.,Nov.23/PRNewswire/--Frost&Sulliv...mpaniesfordemonstratingleadershipandinnovationThur...ovationAwardsBanquetheldinSanAntonio,Texas. ,, ...7/FSLOGO ) ,, TheHealthcareInnovationAwardsareg...ntothedeliveryandmanagementofhealthcare.Suchcompan...
(Date:11/20/2009)... DIEGO, Nov. 20 Veridiam (www.veri... mid-size company category at the 2009 Workplace E...San Diego Society for Human Resources Management a...urces practices. ,, Veridiam was one of nine wi...ted companies, honored at the recent awards ceremo...
(Date:11/20/2009)... METTLER TOLEDO recently announced that... Optimization Using At-Line Particle Characterizat... In this webinar, the application of in situ part...esign space and optimize a series of roller compac... and roller compaction forces. , ...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2[0] YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA[0] Excellence in Healthcare Innovation Recognized by Frost & Sullivan[1] Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category[0] Roller Compaction Process Optimization Using At-Line Particle Characterization
...archived on Company,s web site, GERMANTOWN, Md., ...q: MBRK ), a pharmaceutical company focused on,de...products, today,announced that Dr. Edward M. Rudni...orporate presentation on Tuesday, March 18, 2008, ... take place as part of the Lehman Brothers,Elevent...
...to the proposed merger with Raven ...O, Calif., March 14 VaxGen,Inc. (OTC Bulletin Boa...that its stock is now quoted on the OTC Bulletin B... and assisted VaxGen with the qualification,proces...9991112/VAXGENLOGO ), During 2007, the company wo...
...among those that will be presented by researchers ...tional Laboratory at the American Physical Society...ion Center, New Orleans, Louisiana. Please note th... time of that talk as noted below. All of the rese...asic Energy Sciences within the U.S. Department of...
Other Biology Technology:MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference 2VaxGen Common Stock Now Quoted on OTC Bulletin Board 2VaxGen Common Stock Now Quoted on OTC Bulletin Board 3VaxGen Common Stock Now Quoted on OTC Bulletin Board 4News from the March 2008 American Physical Society Meeting 2News from the March 2008 American Physical Society Meeting 3News from the March 2008 American Physical Society Meeting 4News from the March 2008 American Physical Society Meeting 5(Date:11/23/2009)...ing dangers to human health and the environment. N...project with funding from the U.S. Environmental P...ease that contribute to millions of overflows ever...further reduce the risk of sewage spills. , At i...as opposed to "combined" systems that also handle ...
(Date:11/22/2009)... to tobacco smoke and during childhood to lead fac...research done at Cincinnati Children,s Hospital Me...5 percent of ADHD cases in children between the ag...h of these environmental exposures. This could tra...nd lead exposure each have their own important adv...
(Date:11/22/2009)...crease the likelihood of immune complications foll...l team of researchers reports in the November 22 a... gene, called UGT2B17, is missing from the donor,s...s have a significantly greater risk of a serious s...which immune cells from the donor attack tissues i...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Critical Zone Observatory seeks to answer climate change questions 10146 1Critical Zone Observatory seeks to answer climate change questions 10146 2Critical Zone Observatory seeks to answer climate change questions 10146 3Critical Zone Observatory seeks to answer climate change questions 10146 4Dr Richard Feinman to speak on the science of diabetes and diet on Oct 2 10142 1... have discovered how an unusual protein helps a ce...ting the cell,s self-destruction. , But they also...o4, often makes errors when copying the genomic DN...me cancerous. , The findings by researchers wi...enter are described in two back-to-back papers in ...
...s at the Yerkes National Primate Research Center, ...es use manual gestures of their hands, feet and li...and vocalizations, further supporting the evolutio...tural origin hypothesis of language suggests. This...ings of the National Academy of Sciences. , Worki...
...omatoes get their rich color from lycopene, a dise...ggests that a special variety of orange-colored to...hat our bodies may more readily use. , Researchers... from these orange tomatoes, called Tangerine toma...copene in participants, blood. , "While red tom...
Other Biology News:Protein averts cell suicide but might contribute to cancer 2Protein averts cell suicide but might contribute to cancer 3Ape gestures offer clues to the evolution of human communication 2Unique tomatoes tops in disease-fighting antioxidants 2Unique tomatoes tops in disease-fighting antioxidants 3EPA Peroxidase Prot.Buff from CHEMICON
...Casein Digest Medium (TSB), USP is a highly nutrit...eral laboratory use. Due to the inclusion of both ...growth of many fastidious organisms without the ad...d States Pharmacopeia standards for use in Microbi...
...al and endothelial cells-directed transfection rea...ethylenimine which allows targeted efficient trans...thelial cells. Integrins are adhesion molecules in...sses. Many integrins, including a51 and most aV-co...
WinMelt Software, PC and Windows from Bio-Rad
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |